Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Recardio is a clinical-stage life science company focusing on drug based regenerative therapies for the treatment of cardiovascular diseases. Recardio's headquarters is in San Francisco, California. Roman Schenk is the Founder & CEO of Recardio. Recardio's latest funding round was a Series A for $3M on Nov 2015. Recardio has 2 followers on Owler. Recardio has an estimated revenue of <$1M and an estimate of less <10 employee...
Recardio is a clinical-stage life science company focusing on drug based regenerative therapies for the treatment of cardiovascular diseases. Recardio's headquarters is in San Francisco, California. Roman Schenk is the Founder & CEO of Recardio. Recardio's latest funding round was a Series A for $3M on Nov 2015. Recardio has 2 followers on Owler. Recardio has an estimated revenue of <$1M and an estimate of less <10 employees

List your booth number for exhibitions, ask us